All In Biotech

Free tool

FAERS Monitor: Esomeprazole Magnesium

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214278 or its brand name (Esomeprazole Magnesium, Esomeprazole Magnesium). Reports on generic versions are filed under their own applications.

Reports

62,630

Serious

55,187

88% of reports

Hospitalization

28,204

Death reported

6,327

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • chronic kidney disease5,036
  • acute kidney injury4,745
  • nausea4,386
  • diarrhoea4,167
  • headache3,799
  • fatigue3,798
  • drug ineffective3,635
  • off label use3,621
  • dyspnoea3,491
  • pain2,945
  • vomiting2,920
  • arthralgia2,767
  • pyrexia2,672
  • malaise2,642
  • dizziness2,294

Reports by year received

View as table
YearReports
2004415
2005501
2006349
2007528
2008958
2009768
2010849
2011727
2012798
2013992
20141,148
20151,661
20162,297
20172,675
20185,567
20197,259
20205,076
20214,578
20225,194
20235,435
20245,621
20255,372
20263,861

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,529 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal5,03623.823.1102,904
acute kidney injurySignal4,74510.710.440,782
pyrexiaSignal2,6722.62.52,666
arthralgiaSignal2,7672.22.21,931
diarrhoeaSignal4,1672.22.12,712
vomitingSignal2,9202.12.01,692
dyspnoeaSignal3,4912.12.01,992
headacheSignal3,7992.02.02,066
malaiseSignal2,6422.02.01,399
nausea4,3861.91.81,820
fatigue3,7981.61.6983
pain2,9451.61.6703
dizziness2,2941.51.5452
off label use3,6211.41.3412
drug ineffective3,6350.90.923

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.